Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLCG1 | P19174 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | CCR5 | P51681 | 7/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8042511 | 0.91 | DPP8 (0.36) | PLCG1RAB9ALMNASMN1; SMN2DPP8 | |
| SCHEMBL8698030 | 0.86 | ELANE (0.38) | PLCG1RAB9ASMN1; SMN2ELANECCR5 | |
| SCHEMBL8038903 | 0.84 | PLCG1 (0.38) | PLCG1RAB9ALMNASMN1; SMN2ELANE | |
| SCHEMBL8042506 | 0.84 | LMNA (0.48) | PLCG1RAB9ALMNASMN1; SMN2ELANE | |
| SCHEMBL8038835 | 0.78 | L3MBTL1 (0.36) | PLCG1RAB9ASMN1; SMN2ELANECCR5 | |
| SCHEMBL8045998 | 0.76 | DPP8 (0.37) | PLCG1RAB9ALMNASMN1; SMN2DPP8 | |
| SCHEMBL8046094 | 0.76 | LMNA (0.45) | PLCG1RAB9ALMNASMN1; SMN2DPP8 | |
| SCHEMBL19775159 | 0.75 | PLCG1 (0.42) | PLCG1RAB9ASMN1; SMN2ELANE | |
| SCHEMBL10614763 | 0.75 | PLCG1 (0.43) | PLCG1RAB9ASMN1; SMN2ELANE | |
| SCHEMBL14875146 | 0.74 | PLCG1 (0.42) | PLCG1RAB9ASMN1; SMN2ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5614624-A | THIO SUBSTITUTED, ANTIBIOTICS, CHEMICAL INTERMEDIATES | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | claimed |
| EP-0587436-A1 | Process for preparing carbapenem and penem compounds and new compounds involved in that process | SANKYO COMPANY LIMITED (JP) | 1994-03-16 | — | — | EP | claimed |
| EP-0587436-B1 | Process for preparing carbapenem and penem compounds and new compounds involved in that process | SANKYO CO (JP) | 2000-05-10 | — | — | EP | disclosed |
| US-5681951-A | REACTING PENICILLIN DERIVATIVE HAVING SULFINYL OR SULFONYL GROUP IN 2 POSITION WITH SUBSTITUTED MERCAPTAN IN PRESENCE OF SALT OF GROUP IIA OR IIIA ELEMENT | SANKYO COMPANY, LIMITED (JP) | 1997-10-28 | — | — | US | disclosed |
| US-5614624-A | THIO SUBSTITUTED, ANTIBIOTICS, CHEMICAL INTERMEDIATES | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | disclosed |
| US-5541317-A | PENICILLIN DERIVATIVES, CYCLIZATION OF ESTERS OR THIOESTERS | SANKYO COMPANY, LIMITED (JP) | 1996-07-30 | — | — | US | disclosed |
| EP-0587436-A1 | Process for preparing carbapenem and penem compounds and new compounds involved in that process | SANKYO COMPANY LIMITED (JP) | 1994-03-16 | — | — | EP | disclosed |